183 related articles for article (PubMed ID: 35359781)
1. Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden.
Troberg K; Isendahl P; Blomé MA; Dahlman D; Håkansson A
Front Public Health; 2022; 10():811001. PubMed ID: 35359781
[TBL] [Abstract][Full Text] [Related]
2. Protocol for a multi-site study of the effects of overdose prevention education with naloxone distribution program in Skåne County, Sweden.
Troberg K; Isendahl P; Blomé MA; Dahlman D; Håkansson A
BMC Psychiatry; 2020 Feb; 20(1):49. PubMed ID: 32028921
[TBL] [Abstract][Full Text] [Related]
3. Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals.
Holmén E; Warnqvist A; Kåberg M
Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):24. PubMed ID: 37087485
[TBL] [Abstract][Full Text] [Related]
4. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.
Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
Addiction; 2015 Aug; 110(8):1301-10. PubMed ID: 25917125
[TBL] [Abstract][Full Text] [Related]
5. Risks and overdose responses: Participant characteristics from the first seven years of a national take-home naloxone program.
Ericson ØB; Eide D; Lobmaier P; Clausen T
Drug Alcohol Depend; 2022 Nov; 240():109645. PubMed ID: 36191532
[TBL] [Abstract][Full Text] [Related]
6. Correlates of experiencing and witnessing non-fatal opioid overdoses among individuals accessing harm reduction services in Philadelphia, Pennsylvania.
Pizzicato LN; Johnson CC; Viner KM
Subst Abus; 2020; 41(3):301-306. PubMed ID: 31644397
[No Abstract] [Full Text] [Related]
7. Who is using take-home naloxone? An examination of supersavers.
Eide D; Lobmaier P; Clausen T
Harm Reduct J; 2022 Jun; 19(1):65. PubMed ID: 35717240
[TBL] [Abstract][Full Text] [Related]
8. Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study.
Moustaqim-Barrette A; Papamihali K; Williams S; Ferguson M; Moe J; Purssell R; Buxton JA
PLoS One; 2021; 16(10):e0259126. PubMed ID: 34714854
[TBL] [Abstract][Full Text] [Related]
9. Overdose prevention and naloxone prescription for opioid users in San Francisco.
Enteen L; Bauer J; McLean R; Wheeler E; Huriaux E; Kral AH; Bamberger JD
J Urban Health; 2010 Dec; 87(6):931-41. PubMed ID: 20967505
[TBL] [Abstract][Full Text] [Related]
10. Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario.
Leece PN; Hopkins S; Marshall C; Orkin A; Gassanov MA; Shahin RM
Can J Public Health; 2013 Apr; 104(3):e200-4. PubMed ID: 23823882
[TBL] [Abstract][Full Text] [Related]
11. Opioid education and nasal naloxone rescue kits in the emergency department.
Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
[TBL] [Abstract][Full Text] [Related]
12. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
[TBL] [Abstract][Full Text] [Related]
13. Correlates of take-home naloxone kit possession among people who use drugs in British Columbia: A cross-sectional analysis.
Moustaqim-Barrette A; Papamihali K; Crabtree A; Graham B; Karamouzian M; Buxton JA
Drug Alcohol Depend; 2019 Dec; 205():107609. PubMed ID: 31654839
[TBL] [Abstract][Full Text] [Related]
14. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study.
Doe-Simkins M; Quinn E; Xuan Z; Sorensen-Alawad A; Hackman H; Ozonoff A; Walley AY
BMC Public Health; 2014 Apr; 14():297. PubMed ID: 24684801
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with take-home naloxone kit usage in British Columbia: an analysis of administrative data.
Lei V; Ferguson M; Geiger R; Williams S; Liu L; Buxton JA
Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):25. PubMed ID: 35361228
[TBL] [Abstract][Full Text] [Related]
16. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths.
Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
J Urban Health; 2016 Feb; 93(1):117-30. PubMed ID: 26800987
[TBL] [Abstract][Full Text] [Related]
17. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses.
Strang J; Manning V; Mayet S; Best D; Titherington E; Santana L; Offor E; Semmler C
Addiction; 2008 Oct; 103(10):1648-57. PubMed ID: 18821875
[TBL] [Abstract][Full Text] [Related]
18. Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data.
Moustaqim-Barrette A; Papamihali K; Mamdani Z; Williams S; Buxton JA
PLoS One; 2020; 15(9):e0238618. PubMed ID: 32915834
[TBL] [Abstract][Full Text] [Related]
19. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193
[TBL] [Abstract][Full Text] [Related]
20. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.
Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP
Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
